definiens: or, collectively, as theRECITALSWHEREAS, AVEO and KHK ( as defined herein ) have previously entered into the KHKAgreement ( as defined herein ) under which they have collaborated in the development, manufacture and commercialization of products incorporating the proprietary compound knownas tivozanib for the treatment of cancer, with AVEO holding the rights to develop andcommercialize such products outside of Asia;WHEREAS, [COMPANY] is engaged in the development, manufacturing andcommercialization of pharmaceutical products in the Russian Federation and other CIScountries ; andWHEREAS, [COMPANY] is interested in obtaining an exclusive right and license todevelop, seek marketing authorization for, and to commercialize, tivozanib for use in the Field inthe [COMPANY] Territory ( as each of such terms is defined herein ), and AVEO is willing togrant such rights and licenses to [COMPANY] on the terms set forth herein